The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis
Recruiting
N/A
Interventional Study
Ankylosing Spondylitis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 64
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 60 (estimated)
- Sponsor
- Saglik Bilimleri Universitesi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Subclinical intestinal inflammation and intestinal permeability have been reported in patients with ankylosing spondylitis. Gluten is one of the main triggers of zonulin releaseand gluten intake may contribute to the development of the disease by increasing intestinal permeability. This study aims to determine the impacts of a gluten-freediet on intestinal permeability, sub-clinical intestinal inf…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* diagnosis of axial SpA defined by ASAS criteria
* Adults (aged 18-64 years)
* stable treatment (NSAID and/or DMARD) for at least 3 months
* provide written informed consent and submit to the requirements of the study
Exclusion Criteria:
* Any diet at the time of inclusion or…
Contacts